Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nutrients ; 15(12)2023 Jun 16.
Artículo en Inglés | MEDLINE | ID: mdl-37375680

RESUMEN

Activating brown adipose tissue (BAT) and stimulating white adipose tissue (WAT) browning is a prospective obesity treatment method. Dietary components derived from plants are the most effective approach to activate BAT and promote WAT browning in rodents. This study investigated the synergistic effects of Panax ginseng (PG) and Diospyros kaki leaf (DKL) extract on adipocyte differentiation and browning, as well as the molecular mechanism underlying their beneficial effects. The administration of PG and DKL to HFD-induced obese mice significantly decreased body weight and epididymal and abdominal adipose tissue mass. In in vitro, PG inhibited the adipogenesis of 3T3-L1 adipocytes by regulating the expression of key adipogenic regulators, such as peroxisome proliferator-activated receptor (PPAR)γ and CCAAT/enhancer-binding protein (C/EBP)-α. In contrast, DKL negligibly influenced the adipogenesis of 3T3-L1 adipocytes but greatly increased the protein expression of UCP-1, PGC-1α, and PPARα in BAT and/or WAT. Moreover, PG and DKL inhibited adipogenesis synergistically and activated white adipocyte browning via AMP-activated protein kinase (AMPK) and sirtuin 1 (SIRT1) pathways. These results suggest that a combination of PG and DKL regulates adipogenesis in white adipocytes and browning in brown adipocytes by activating AMPK/SIRT1 axis. The potential use of PG and DKL may represent an important strategy in obesity management that will be safer and more effective.


Asunto(s)
Diospyros , Panax , Ratones , Animales , Adipocitos Blancos , Proteínas Quinasas Activadas por AMP/metabolismo , Panax/química , Sirtuina 1/metabolismo , Estudios Prospectivos , Adipogénesis , PPAR gamma/metabolismo , Proteína alfa Potenciadora de Unión a CCAAT/genética , Proteína alfa Potenciadora de Unión a CCAAT/metabolismo , Hojas de la Planta/metabolismo , Células 3T3-L1
2.
Dis Markers ; 35(6): 679-85, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24311892

RESUMEN

BACKGROUND AND AIM: It is well known that androgen deprivation relates to penile fibrosis, so we hypothesize that long-term treatment with 5-alphareductase inhibitors (5ARIs) may increase the risk of fibrosis of prostate. PATIENTS AND METHODS: Thirty-two BPH patients who underwent transurethral resection of the prostate were enrolled. The patients were divided into two groups: group one, 16 patients underwent TURP who had been treated with tamsulosin for 2 years; group two, 16 patients underwent TURP who had been treated with combination of tamsulosin and dutasteride for at least 1 year. We evaluated the expressions of nNOS, iNOS, eNOS, TGF-ß1, TGF-ß2, phosphorylated-Smad2/3 (p-Smad2/3), E-cadherin, N-cadherin, and α-smooth muscle actin in the resected prostate tissues by western blotting, and the TGF-ß concentration was determined by ELISA kit. RESULTS: The expressions of 3 isoforms of NOS were significantly increased in group 2 except of eNOS in lateral prostate, and the expressions of TGF-ß1, TGF-ß2, and p-Smad2/3 increased about 2-fold compared with group 1. In group 2, the E-cadherin expression decreased while N-cadherin expression increased significantly. CONCLUSIONS: The overexpression of nNOS may contribute to prostate smooth muscle relaxation; however, long-time treatment with 5 ARI increases the risk of fibrosis of prostate.


Asunto(s)
Inhibidores de 5-alfa-Reductasa/farmacología , Hiperplasia Prostática/metabolismo , Sulfonamidas/farmacología , Factor de Crecimiento Transformador beta1/metabolismo , Factor de Crecimiento Transformador beta2/metabolismo , Inhibidores de 5-alfa-Reductasa/uso terapéutico , Antígenos CD/metabolismo , Cadherinas/metabolismo , Terapia Combinada , Humanos , Hipertrofia/metabolismo , Masculino , Óxido Nítrico Sintasa/metabolismo , Próstata/efectos de los fármacos , Próstata/metabolismo , Próstata/patología , Próstata/cirugía , Hiperplasia Prostática/tratamiento farmacológico , Hiperplasia Prostática/cirugía , Transducción de Señal , Proteína Smad2/metabolismo , Proteína smad3/metabolismo , Sulfonamidas/uso terapéutico , Tamsulosina , Resección Transuretral de la Próstata
3.
BMC Complement Altern Med ; 11: 120, 2011 Nov 28.
Artículo en Inglés | MEDLINE | ID: mdl-22118263

RESUMEN

BACKGROUND: Salvia miltiorrhiza (SM) has long been used as a traditional oriental medicine for cardiovascular disease. Accumulating evidence also indicates that SM has anti-osteoporotic effects. This study was conducted to examine the SM-induced anti-osteoporotic effect and its possible mechanisms with various doses of SM. METHODS: We studied Sprague-Dawley female rats aged 12 weeks, divided into six groups: sham-operated control (SHAM), OVX rats supplemented with SM (1, 3, 10 and 30 mg/kg) orally for 8 weeks. At the end of the experiment, blood samples were collected and biochemistry analysis was performed. Specimens from both tibia and liver were processed for light microscopic examination. DEXA and µ-CT analyses of the tibia were also performed. RESULTS: SM treatment significantly ameliorated the decrease in BMD and trabecular bone mass according to DEXA and trabecular bone architecture analysis of trabecular bone structural parameters by µ-CT scanning. In serum biochemical analysis, SM decreased the released TRAP-5b, an osteoclast activation marker and oxidative stress parameters including MDA and NO induced by OVX. CONCLUSIONS: The preventive effect of SM was presumably due to its anti-oxidative stress partly via modulation of osteoclast maturation and number. In current study, SM appears to be a promising osteoporosis therapeutic natural product.


Asunto(s)
Conservadores de la Densidad Ósea/uso terapéutico , Densidad Ósea/efectos de los fármacos , Osteoporosis Posmenopáusica/tratamiento farmacológico , Estrés Oxidativo/efectos de los fármacos , Fitoterapia , Extractos Vegetales/uso terapéutico , Salvia miltiorrhiza , Animales , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Conservadores de la Densidad Ósea/farmacología , Femenino , Humanos , Malondialdehído/sangre , Óxido Nítrico/sangre , Osteoclastos/efectos de los fármacos , Osteoporosis Posmenopáusica/diagnóstico por imagen , Osteoporosis Posmenopáusica/prevención & control , Ovariectomía , Extractos Vegetales/farmacología , Radiografía , Ratas , Ratas Sprague-Dawley , Tibia/anatomía & histología , Tibia/efectos de los fármacos , Tibia/metabolismo
4.
Immunopharmacol Immunotoxicol ; 30(2): 333-45, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18569088

RESUMEN

In this study, the authors have characterized the effect of HER-S (red ginseng, Angelicae gigantis Radix, Phyllostachys folium, and soybean extracts) on osteoporosis-associated phenomena in ovariectomized (OVX) rats by measuring body weights and bone histomorphometries in control, sham, OVX, OVX(beta-estradiol-treated), and OVX(HER-S-treated) rats. Light microscopic analyses showed a porous or eroded appearance on the femoral trabecular bone surface in OVX rats, whereas the femoral trabecular bone surfaces of the other groups (control, sham, OVX(17beta-estradiol-treated), and OVX(HER-S-treated) rats) were composed of fine particles. The femoral trabecular bone area and number were decreased in OVX rats, but these reductions were significantly prevented by the administration of HER-S for 7 weeks, similar to estrogen. In the blood biochemistry results, serum phosphorus, calcium, T(3), and T(4) remained unchanged, but blood estrogen levels were significantly increased in HER-S-treated rats, which suggests that estrogen is related to the mechanism of the HER-S-induced antiosteoporosis function in OVX rats.


Asunto(s)
Osteoporosis/tratamiento farmacológico , Panax/química , Extractos Vegetales/farmacología , Animales , Calcio/metabolismo , Línea Celular , Estradiol/sangre , Estradiol/farmacología , Femenino , Fémur/metabolismo , Fémur/patología , Osteoporosis/sangre , Osteoporosis/patología , Ovariectomía , Fósforo/metabolismo , Extractos Vegetales/química , Ratas , Ratas Sprague-Dawley , Hormonas Tiroideas/sangre , Factores de Tiempo
5.
Immunopharmacol Immunotoxicol ; 29(3-4): 439-49, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-18075856

RESUMEN

High molecular weight water-soluble chitosan(WSC), having an average molecular weight of 300,000 Da and a degree of deacethylation over 90%, can be produced using a simple multi-step membrane separation process. In this study, the trabecular bone area and thickness in ovariectomized(OVX) rats decreased by almost 50% from those in sham-operated rats. WSC was evaluated for inhibition of the progress of bone loss induced by OVX rats. We measured bone histomorphometry in sham, OVX or WSC-administered OVX rats. From light microscopic analyses, a porous or erosive appearances were observed on the surface of trabecular bone of tibia in OVX rats, whereas those of the same bone in sham-operated rats were composed of fine particles. The trabecular bone area and trabecular thickness in OVX rats decreased by 50% from those in sham rats, these decreases were completely inhibited by administration of WSC at a concentration of 15 mg/kg/daily for 7 weeks. In this study, the mechanical strength in femur neck was significantly enhanced by the treatment of WSC for 7 weeks. In OVX rats, free T(3) was normal in all cases, whereas free T(4) was significantly increased. Although there was no difference between OVX and WSC-administered rats in T(3) level, we have found significant difference between them in T(4) level. These results strongly suggest that WSC is effective in preventing the development of bone loss induced by OVX in rats.


Asunto(s)
Huesos/efectos de los fármacos , Quitosano/química , Quitosano/farmacología , Ovariectomía , Malla Trabecular/efectos de los fármacos , Fosfatasa Alcalina/sangre , Animales , Fenómenos Biomecánicos , Huesos/anatomía & histología , Calcio/sangre , Calcio de la Dieta/farmacología , Modelos Animales de Enfermedad , Femenino , Cuello Femoral/anatomía & histología , Cuello Femoral/efectos de los fármacos , Humanos , Peso Molecular , Osteoblastos/efectos de los fármacos , Osteoclastos/efectos de los fármacos , Fósforo/sangre , Ratas , Ratas Sprague-Dawley , Solubilidad , Tiroxina/sangre , Malla Trabecular/anatomía & histología , Agua
6.
Life Sci ; 80(4): 314-23, 2007 Jan 02.
Artículo en Inglés | MEDLINE | ID: mdl-17034819

RESUMEN

Plantainoside D (PD), was isolated from the leaves of Picrorhiza scrophulariiflora (Scrophulariaceae). The anti-oxidative activity of PD was evaluated based on scavenging effects on hydroxyl radicals and superoxide anion radicals. Adriamycin (ADR) is a potent anti-tumor drug known to cause severe cardiotoxicity. Although ADR generates free radicals, the role of free radicals in the development of cardiac toxicity has not been understood. This study was undertaken to investigate the protective effect of PD against ADR-induced apoptosis. In vitro, ADR caused dose-dependent toxicity in H9c2 cardiac muscle cells. Pre-treatment of the cardiac muscle cells with PD significantly reduced ADR-induced apoptosis of cardiac muscle cells. PD inhibited the ROS produced by ADR in the cardiac muscle cells. As well, PD increased GSH(glutathione), compared with ADR. In response to ADR, NF-kappaB was activated in H9c2 cells. However the treatment of PD reduced the activation of NF-kappaB. We also observed that the NF-kappaB inhibitor, PDTC, inhibited the cytotoxic effect on ADR-induced apoptosis in cardiac muscle cells. In parallel, IkappaBalpha-dominant negative plasmid-overexpression abrogated ADR-induced apoptosis in H9c2 cardiac muscle cells. In conclusion, these results suggest that Plantaionoside D can inhibit ADR-induced apoptosis in H9C2 cardiac muscle cells via inhibition of ROS generation and NF-kappaB activation. The pure compound PD can be a potential candidate agent which protects cardiotoxicity in ADR-exposed patients.


Asunto(s)
Antibióticos Antineoplásicos/toxicidad , Apoptosis/efectos de los fármacos , Ácidos Cumáricos/farmacología , Disacáridos/farmacología , Doxorrubicina/toxicidad , Miocardio/patología , FN-kappa B/metabolismo , Especies Reactivas de Oxígeno/antagonistas & inhibidores , Scrophulariaceae/química , Animales , Antioxidantes/farmacología , Línea Celular/efectos de los fármacos , Línea Celular/patología , Supervivencia Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Glutatión/metabolismo , Corazón/efectos de los fármacos , Potencial de la Membrana Mitocondrial/efectos de los fármacos , Miocardio/metabolismo , FN-kappa B/antagonistas & inhibidores , Extractos Vegetales/farmacología , Hojas de la Planta/química , Prolina/análogos & derivados , Prolina/farmacología , Ratas , Tiocarbamatos/farmacología
7.
Life Sci ; 76(18): 2027-42, 2005 Mar 18.
Artículo en Inglés | MEDLINE | ID: mdl-15826871

RESUMEN

This study examined the effect of Saeng-Ji-Hwang (SJH: Radix Rehmanniae) on cardiac muscle cells. Adriamycin-exposed H9C2 cardiac muscle cells were treated with a water extract of SJH. The adriamycin induced cell death and caspase-3 activation were significantly inhibited by SJH (2 mg/ml), which can be explained by the increase in Bcl-2 expression and the inhibition of Bax expression. Adriamycin reduced the Mn-SOD protein expression level in H9C2 cardiac muscle cells but a SJH treatment partially but significantly reversed this effect. Manganese (Mn)-TBAP or Mn-TMyM--mitochondria-specific SOD mimetic agent--reduced the adriamycin-induced cytotoxicity. It was also shown that SJH inhibits the release of H2O2 and prevents lipid peroxidation in the presence of adriamycin. This study examined the intracellular GSH level, which showed that adriamycin significantly decreased the intracellular GSH level but SJH increased it. BSO, a selective inhibitor of glutamyl cysteinyl ligase, which is a rate-limiting enzyme in GSH synthesis, did not affect the viability of the cardiac muscle cells. However, a combination of BSO with SJH in the presence of adriamycin reversed the SJH-induced protection. Overall, the results suggest that SJH-associated Mn-SOD and GSH are important factors in the mechanism of the SJH-induced protective mechanism in H9C2 cardiac muscle cells.


Asunto(s)
Antibióticos Antineoplásicos/toxicidad , Doxorrubicina/toxicidad , Medicamentos Herbarios Chinos/farmacología , Miocitos Cardíacos/efectos de los fármacos , Rehmannia/química , Animales , Antibióticos Antineoplásicos/antagonistas & inhibidores , Apoptosis , Caspasa 3 , Caspasas/metabolismo , Línea Celular , Doxorrubicina/antagonistas & inhibidores , Glutatión/análisis , Peróxido de Hidrógeno/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Superóxido Dismutasa/metabolismo , Proteína X Asociada a bcl-2
8.
Life Sci ; 75(25): 2997-3016, 2004 Nov 05.
Artículo en Inglés | MEDLINE | ID: mdl-15474552

RESUMEN

Ge-Jee-Bok-Ryung-Hwan (GJBRH), a commonly used herb formulation in Korea, Japan and China, caused a decrease of viability in HeLa human cervical carcinoma cells. The treatment of GJBRH resulted in genomic DNA fragmentation as well as the increase of Sub-G1 portion in cell cycle analysis. In this study, GFP-Bax over-expression system showed that Bax, pro-apoptotic Bcl-2 family protein, was translocated to mitochondria by the presence of GJBRH. The treatment of BAPTA-AM, permeable endogenous calcium chelator, inhibited GJBRH-induced caspase-3 and -9 activations, the release of cytochrome c and Smac/DIABLO into cytoplasm and the resultant cell death in HeLa human cervical carcinoma cells. The treatment of BAPTA-AM increased the expression of XIAP, which mediates binding to and inhibiting caspases and showed protective effect, in GJBRH-treated cells. GJBRH induced the expression of Glucose Response Protein 78 (GRP 78), a positive ER stress marker protein. However, BAPTA-AM did not interfere with the ER-stress response pathway that triggers the expression of GRP 78. This study showed that GJBRH induces cell death, which occurs downstream of or parallel to this point in the ER-stress pathway linked to apoptosis. In conclusion, GJBRH induces apoptosis in HeLa cells via ER stress-pathway associated mitochondria-dependent apoptosis mechansim.


Asunto(s)
Apoptosis/efectos de los fármacos , Medicamentos Herbarios Chinos/farmacología , Ácido Egtácico/análogos & derivados , Retículo Endoplásmico/efectos de los fármacos , Proteínas , Señalización del Calcio , Caspasa 3 , Caspasa 9 , Caspasas/metabolismo , Ácido Egtácico/farmacología , Retículo Endoplásmico/fisiología , Chaperón BiP del Retículo Endoplásmico , Células HeLa , Proteínas de Choque Térmico/biosíntesis , Humanos , Potenciales de la Membrana/efectos de los fármacos , Chaperonas Moleculares/biosíntesis , Poli(ADP-Ribosa) Polimerasas/metabolismo , Biosíntesis de Proteínas , Transporte de Proteínas/efectos de los fármacos , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo , Proteína Inhibidora de la Apoptosis Ligada a X , Proteína X Asociada a bcl-2
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA